About the Company
advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TXG News
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping the ...
Q4 2023 10X Genomics Inc Earnings Call
Cassie Corneau; Manager of IR and Strategic Finance; 10x Genomics, Inc. Justin J. McAnear; CFO; 10x Genomics, Inc. Serge Saxonov; Co-Founder, CEO & Director; 10x ...
10x Genomics
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...
10x Genomics Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
10X Genomics Inc (TXG)
10x Genomics (NASDAQ:TXG) reported Q4 EPS of ($0.15), $0.14 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $156.2 million versus the consensus ...
NanoString scores legal victory in patent fight with competitor
Seattle-based research device company NanoString Technologies Inc. (Nasdaq: NSTG) has struck back in a brutal patent litigation fight with competitor 10x Genomics Inc. (Nasdaq: TXG). On Monday ...
10x Genomics begins shipping Chromium GEM-X products
10x Genomics (NASDAQ:TXG) said it has begun shipping the first two products powered by its next-generation GEM-X technology ...
10x Genomics, Inc: 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
The next generation of the company's leading single cell technology architecture, GEM-X, enables higher performance at larger scale and lower cost PLEASANTON, Calif., March 13, 2024 /PRNewswire/ -- ...
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
These forward-looking statements include statements regarding 10x Genomics, Inc.'s ("10x Genomics") product launches, performance, configuration, costs, capabilities, adoption and pipeline. These ...
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
These forward-looking statements include statements regarding 10x Genomics, Inc.'s ("10x Genomics") product launches, performance, configuration, costs, capabilities, adoption and pipeline.
10x Genomics begins shipping Chromium GEM-X products
10x Genomics (NASDAQ:TXG) said it has begun shipping the first two products powered by its next-generation GEM-X technology architecture. The life sciences technology company said the first ...
Loading the latest forecasts...